We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGR
1801
DELISTED
Avangrid, Inc.
AGR
| $2.51M | ﹤0.01% |
50,414
-3,083
| -6% | -$145K |
|
1802
MacroGenics
MGNX
$257M
| $2.51M | ﹤0.01% |
78,792
-5,632
| -7% | -$137K |
|
|
MIME
1803
DELISTED
Mimecast Limited
MIME
| $2.51M | ﹤0.01% |
62,328
-4,828
| -7% | -$213K |
|
|
HOME
1804
DELISTED
At Home Group Inc.
HOME
| $2.5M | ﹤0.01% |
87,235
-4,235
| -5% | -$106K |
|
1805
Array Technologies
ARRY
$855M
| $2.5M | ﹤0.01% |
83,858
+27,278
| +48% | +$1.09M |
|
|
SPTN
1806
DELISTED
SpartanNash
SPTN
| $2.5M | ﹤0.01% |
127,396
+2,763
| +2% | +$52.3K |
|
|
ARR
1807
Armour Residential REIT
ARR
$2.36B
| $2.5M | ﹤0.01% |
40,981
-913
| -2% | -$53.6K |
|
|
INOV
1808
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $2.49M | ﹤0.01% |
86,555
-7,577
| -8% | -$195K |
|
|
AGNT
1809
AGNT Inc
AGNT
$734M
| $2.49M | ﹤0.01% |
54,611
-5,385
| -9% | -$287K |
|
1810
Super Micro Computer
SMCI
$20.1B
| $2.48M | ﹤0.01% |
636,010
-48,140
| -7% | -$164K |
|
|
PGRE
1811
DELISTED
Paramount Group
PGRE
| $2.48M | ﹤0.01% |
244,504
-8,583
| -3% | -$80.6K |
|
1812
Collegium Pharmaceutical
COLL
$956M
| $2.47M | ﹤0.01% |
104,387
+56,692
| +119% | +$1.35M |
|
|
RC
1813
Ready Capital
RC
$308M
| $2.47M | ﹤0.01% |
184,122
+51,605
| +39% | +$669K |
|
|
RVNC
1814
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.47M | ﹤0.01% |
88,329
-7,492
| -8% | -$207K |
|
|
HTO
1815
H2O America
HTO
$2.62B
| $2.47M | ﹤0.01% |
39,159
-2,563
| -6% | -$167K |
|
1816
PC Connection
CNXN
$2.12B
| $2.46M | ﹤0.01% |
53,124
+14,967
| +39% | +$740K |
|
1817
Perdoceo Education
PRDO
$2.12B
| $2.46M | ﹤0.01% |
205,265
+3,292
| +2% | +$41.6K |
|
|
GBT
1818
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.45M | ﹤0.01% |
60,233
-3,324
| -5% | -$153K |
|
1819
Newmark Group
NMRK
$2.63B
| $2.44M | ﹤0.01% |
243,858
-15,212
| -6% | -$136K |
|
|
TDAY
1820
USA Today Co
TDAY
$1.06B
| $2.43M | ﹤0.01% |
451,151
+7,969
| +2% | +$39K |
|
1821
Schrodinger
SDGR
$1.36B
| $2.43M | ﹤0.01% |
31,811
-3,770
| -11% | -$339K |
|
|
MIC
1822
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $2.42M | ﹤0.01% |
76,075
-3,341
| -4% | -$105K |
|
|
MDLA
1823
DELISTED
Medallia, Inc.
MDLA
| $2.42M | ﹤0.01% |
86,725
-1,609
| -2% | -$59.7K |
|
|
CIVI
1824
DELISTED
Civitas Resources
CIVI
| $2.42M | ﹤0.01% |
67,605
-702
| -1% | -$19.8K |
|
|
CVA
1825
DELISTED
Covanta Holding Corporation
CVA
| $2.41M | ﹤0.01% |
173,803
-24,720
| -12% | -$353K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.